Logos Global Management LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001792126

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q1 2025 · 39 positions · Total reported value $562.54M · Top-10 concentration 62.0% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 72.7% · 25 new · 19 cut · 20 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +22.9% · vs SPY +8.1% · Prev Value $1.89B — last quarter positions weighted by this quarter price moves · ranking

In its Q1 2025 13F filing, Logos Global Management LP disclosed 39 equity positions with a combined reported value of $562.54M. The filing implies a focused portfolio: its ten largest positions account for 62.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2025 were IDYA ($57.33M), RVMD ($56.58M), AKRO ($48.58M). By sector, the heaviest allocations are Health Care 73.3%, Other 26.7%. Versus the prior quarter, allocation shifted toward Other (+10.6pp) and away from Health Care (-10.6pp).

Versus the prior quarter, Logos Global Management LP opened 25 new positions, trimmed 19 and fully exited 20, a turnover rate of 72.7% of positions. The portfolio's overlap with the prior quarter was 48% of names.

The largest new positions opened in Q1 2025 were NUVL ($35.46M), TEVA ($26.13M), XENE ($21.81M).

Of the 20 positions fully exited versus the prior quarter, the largest were CYTK ($42.34M), VERA ($37.00M), MRUS ($31.54M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2025)

  • NUVL NUVALENT INC · $35.46M
  • TEVA TEVA PHARMACEUTICAL INDS LTD · $26.13M
  • XENE XENON PHARMACEUTICALS INC · $21.81M
  • KROS KEROS THERAPEUTICS INC · $20.38M
  • ETNB 89BIO INC · $18.18M
  • MLTX MOONLAKE IMMUNOTHERAPEUTICS · $13.67M
  • CRNX CRINETICS PHARMACEUTICALS IN · $11.74M
  • RNAM AVIDITY BIOSCIENCES INC · $10.33M

Fully Exited (vs previous quarter)

  • CYTK CYTOKINETICS INC · prev qtr: $42.34M
  • VERA VERA THERAPEUTICS INC · prev qtr: $37.00M · history
  • MRUS MERUS N V · prev qtr: $31.54M
  • INSM INSMED INC · prev qtr: $31.07M
  • NBIX NEUROCRINE BIOSCIENCES INC · prev qtr: $27.30M
  • PCVX VAXCYTE INC · prev qtr: $24.56M
  • JAZZ JAZZ PHARMACEUTICALS PLC · prev qtr: $21.55M
  • BPMC BLUEPRINT MEDICINES CORP · prev qtr: $17.44M

Insider Transactions (Form 4)

Latest Logos Global Management LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Logos Global Management LP is an SEC-registered 13F filer based in San Francisco, CA, United States. As of Q2 2026 it reported 68 US equity positions with a combined value of $2.32B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SAN FRANCISCO, CA, United States
  • SEC registration: 801-117248 (status: Approved), registered 2019-08-26
  • Regulatory AUM (Form ADV): $2.25B as of 2026-04-22
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 5 private funds, of which 1 hedge funds

Portfolio Structure

  • 68 positions · $2.32B reported value (Q2 2026)
  • Top 10 holdings = 48.3% of reported value
  • Largest position: ERAS (ERASCA INC COM) at 9.6%
  • Average position size: $34.16M

Sector Tilt

  • Health Care 99.1%
  • Financials 0.1%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 25 new, 18 added, 19 reduced, 20 exited
  • 6 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 73.3%
Other 26.7%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 3.50M $57.33M 10.19%
10.19%
Add
2 1.60M $56.58M 10.06%
10.06%
Add
3 1.20M $48.58M 8.63%
8.63%
Add
4 1.65M $44.55M 7.92%
7.92%
Add
5 500.00K $35.46M 6.30%
6.30%
New
6 1.70M $26.13M 4.64%
4.64%
New
7 650.00K $21.81M 3.88%
3.88%
New
8 2.00M $20.38M 3.62%
3.62%
New
9 394.34K $19.58M 3.48%
3.48%
Add
10 200.00K $18.21M 3.24%
3.24%
Reduce
11 2.50M $18.18M 3.23%
3.23%
New
12 250.00K $17.86M 3.17%
3.17%
Reduce
13 13.00M $17.81M 3.17%
3.17%
Add
14 2.30M $16.86M 3.00%
3.00%
Reduce
15 4.22M $16.28M 2.89%
2.89%
Hold
16 350.00K $13.67M 2.43%
2.43%
New
17 8.00M $12.72M 2.26%
2.26%
Add
18 3.21M $12.07M 2.15%
2.15%
Hold
19 350.00K $11.74M 2.09%
2.09%
New
20 350.00K $10.33M 1.84%
1.84%
New
21 936.91K $10.32M 1.83%
1.83%
New
22 4.00M $7.72M 1.37%
1.37%
Add
23 425.00K $7.36M 1.31%
1.31%
Reduce
24 2.00M $5.72M 1.02%
1.02%
New
25 500.00K $5.23M 0.93%
0.93%
Add
26 240.00K $4.72M 0.84%
0.84%
Add
27 275.00K $4.70M 0.83%
0.83%
Reduce
28 1.40M $3.51M 0.62%
0.62%
Hold
29 2.22M $3.40M 0.60%
0.60%
Hold
30 5.08M $2.92M 0.52%
0.52%
Hold
31 424.71K $2.67M 0.47%
0.47%
Reduce
32 500.00K $2.67M 0.47%
0.47%
Hold
33 208.91K $2.10M 0.37%
0.37%
Hold
34 5.40M $1.13M 0.20%
0.20%
Hold
35 134.20K $777.03K 0.14%
0.14%
Hold
36 2.90M $660.04K 0.12%
0.12%
Hold
37 145.09K $435.27K 0.08%
0.08%
Hold
38 100.00K $370.00K 0.07%
0.07%
New
39 66.67K $15.92K 0.00%
0.00%
Hold

FAQ

What did Logos Global Management LP buy in 2025-Q1?

In its 2025-Q1 13F filing, Logos Global Management LP reported 39 equity positions worth $562.54M in aggregate; its largest disclosed positions were IDYA ($57.33M), RVMD ($56.58M), AKRO ($48.58M).

How large is Logos Global Management LP's portfolio?

Logos Global Management LP reported $562.54M of long equity holdings across 39 positions as of 2025-Q1. Top-10 holdings account for 62.0% of reported value.

What is Logos Global Management LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/logos-global-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →